Dengue virus, vivo atenuado serotipo

Qdenga Polvo y Disolvente Para Solucion Inyectable en Jeringa Precargada

≥ 3,3 log10 Unidades formadoras de placa/dosis (UFP/DOSIS) + ≥ 2,7 log10 Unidades formadoras de placa/dosis (UFP/DOSIS) + ≥ 4 log10 Unidades formadoras de placa/dosis (UFP/DOSIS) + ≥ 4,5 log10 Unidades formadoras de placa/dosis polvo y disolvente para solución inyectableSpainMarketedAuthorised 15 Dec 2022

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

QdengaEuropean UnionAuthorised

Packs

Pack	Code	Status
QDENGA POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE EN JERINGA PRECARGADA, 1 vial y 1 jeringa precargada	758837

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Dengue virus, vivo atenuado serotipo

Qdenga Polvo y Disolvente Para Solucion Inyectable en Jeringa Precargada

≥ 3,3 log10 Unidades formadoras de placa/dosis (UFP/DOSIS) + ≥ 2,7 log10 Unidades formadoras de placa/dosis (UFP/DOSIS) + ≥ 4 log10 Unidades formadoras de placa/dosis (UFP/DOSIS) + ≥ 4,5 log10 Unidades formadoras de placa/dosis polvo y disolvente para solución inyectableSpainMarketedAuthorised 15 Dec 2022

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

QdengaEuropean UnionAuthorised

Packs

Pack	Code	Status
QDENGA POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE EN JERINGA PRECARGADA, 1 vial y 1 jeringa precargada	758837

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Register entryAEMPS

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Dengue virus, vivo atenuado serotipo
Strength: ≥ 3,3 log10 Unidades formadoras de placa/dosis (UFP/DOSIS) + ≥ 2,7 log10 Unidades formadoras de placa/dosis (UFP/DOSIS) + ≥ 4 log10 Unidades formadoras de placa/dosis (UFP/DOSIS) + ≥ 4,5 log10 Unidades formadoras de placa/dosis
Dosage form: polvo y disolvente para solución inyectable
Route: vía subcutánea
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 15 Dec 2022
Registration: 1221699005
Marketing authorisation holder: Takeda Pharmaceuticals International Ag Ireland Branch
Procedure: EU centralised
Supply: Medicamento Sujeto A Prescripción Médica
EU number: EU/1/22/1699